What is the share price of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) today?
The share price of IOLCP as on 12th June 2025 is ₹90.18. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The past returns of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share are- Past 1 week: 6.10%
- Past 1 month: 43.36%
- Past 3 months: 45.10%
- Past 6 months: 7.94%
- Past 1 year: 15.20%
- Past 3 years: 27.01%
- Past 5 years: 10.04%
What are the peers or stocks similar to IOL Chemicals and Pharmaceuticals Ltd (IOLCP)?
The peers or stocks similar to IOL Chemicals and Pharmaceuticals Ltd (IOLCP) include:What is the dividend yield % of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The current dividend yield of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 4.44.What is the market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹2647.03 Cr as of 12th June 2025.What is the 52 week high and low of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The 52-week high of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹107.54 and the 52-week low is ₹57.50.What is the PE and PB ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) stock?
The P/E (price-to-earnings) ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 26.19. The P/B (price-to-book) ratio is 1.64.Which sector does IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belong to?
IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares?
You can directly buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares on Tickertape. Simply sign up, connect your demat account and place your order.
IOL Chemicals and Pharmaceuticals Ltd
IOLCP Share Price
90.182.83% (-2.63)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
IOLCP Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
IOLCP Performance & Key Metrics
IOLCP Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 26.19 | 1.64 | 4.44% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.38 | 3.48 | 1.59% |
100%
Analysts have suggested that investors can buy this stock
from 2 analysts
Price Upside
Earnings Growth
Rev. Growth
IOLCP Company Profile
IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.
SOLARINDS
PE Ratio
124.59
124.59
1Y Return
77.15%
77.15%
Buy Reco %
80.00
80.00
LINDEINDIA
PE Ratio
134.84
134.84
1Y Return
21.83%
21.83%
Buy Reco %
50.00
50.00
DEEPAKNTR
PE Ratio
37.76
37.76
1Y Return
17.92%
17.92%
Buy Reco %
60.00
60.00
SUMICHEM
PE Ratio
49.07
49.07
1Y Return
1.80%
1.80%
Buy Reco %
100.00
100.00
PE Ratio
42.36
42.36
1Y Return
31.57%
31.57%
Buy Reco %
100.00
100.00
IOLCP Sentiment Analysis
IOLCP Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
IOLCP Stock Summary · May 2025
The company demonstrated resilience in Q4 FY '25, achieving growth in revenue and EBITDA despite facing pricing pressures in the pharmaceutical sector due to global oversupply. Significant investments, including a new Paracetamol unit and plans for greenfield expansion, underscore its commitment to enhancing production capacity and diversifying its product offerings. With a strong balance sheet reflected in a low net debt to equity ratio, management remains optimistic about future growth, particularly in export revenues, which they aim to increase from 27% to 40%. Operational efficiencies and strategic cost management are pivotal as the company navigates market challenges, while regulatory approvals for key products bolster its international expansion efforts. Overall, the outlook remains positive, with expectations for improved margins and sustained demand across various therapeutic categories.
IOLCP Stock Growth Drivers
IOLCP Stock Growth Drivers
6Increased Production Capacity and Diversification
IOL Chemicals and Pharmaceuticals Limited has successfully commissioned a fully backward integrated Paracetamol unit at
Resilient Financial Performance
In Q4 of FY 2025, the company reported a revenue from operations of INR 528
IOLCP Stock Challenges
IOLCP Stock Challenges
4Pricing Pressures and Revenue Decline
The company has faced significant pricing pressures in both the pharmaceutical and chemicals sectors, leading
Export Challenges and Market Underutilization
The company's export percentage has decreased from 29-30% in FY '23 to 27% in FY
IOLCP Forecast
IOLCP Forecasts
Price
Revenue
Earnings
IOLCP Share Price Forecast
IOLCP Share Price Forecast
2025
Current
₹90.18
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹90.18
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
IOLCP Company Revenue Forecast
IOLCP Company Revenue Forecast
2025
Current
₹2.10
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹2.10
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
IOLCP Stock EPS (Earnings Per Share) Forecast
IOLCP Stock EPS (Earnings Per Share) Forecast
2025
Current
₹3.44
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹3.44
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
IOLCP
IOLCP
Income
Balance Sheet
Cash Flow
Annual Normal View
IOLCP Income Statement
IOLCP Income Statement
Annual Normal View
| Financial Year | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,216.06 | 2,242.72 | 2,162.86 | 2,101.62 | 2,101.61 | |||||
Raw Materials | 1,622.81 | 1,565.29 | 1,435.20 | 1,876.91 | 1,876.90 | |||||
| Power & Fuel Cost | 78.18 | 131.98 | 149.05 | |||||||
| Employee Cost | 141.30 | 168.21 | 201.02 | |||||||
| Selling & Administrative Expenses | 71.96 | 68.39 | 60.26 | |||||||
| Operating & Other expenses | 25.41 | 57.57 | 56.67 | |||||||
EBITDA | 276.40 | 251.28 | 260.66 | 224.71 | 224.71 | |||||
| Depreciation/Amortization | 43.26 | 46.16 | 62.91 | 71.99 | 71.99 | |||||
| PBIT | 233.14 | 205.12 | 197.75 | 152.72 | 152.72 | |||||
| Interest & Other Items | 8.29 | 16.47 | 16.10 | 14.76 | 14.76 | |||||
| PBT | 224.85 | 188.65 | 181.65 | 137.96 | 137.96 | |||||
| Taxes & Other Items | 57.18 | 49.51 | 47.22 | 36.89 | 36.89 | |||||
| Net Income | 167.67 | 139.14 | 134.43 | 101.07 | 101.07 | |||||
| EPS | 5.71 | 4.74 | 4.58 | 3.44 | 3.44 | |||||
| DPS | 0.80 | 0.80 | 1.00 | 4.00 | 0.80 | |||||
| Payout ratio | 0.14 | 0.17 | 0.22 | 1.16 | 0.23 |
IOLCP Company Updates
FY 2025FY 2025
Investor Presentation
May 19PDF
Feb 13PDF
Nov 18PDF
IOLCP Stock Peers
IOLCP Past Performance & Peer Comparison
IOLCP Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| IOL Chemicals and Pharmaceuticals Ltd | 26.19 | 1.64 | 4.44% |
| Solar Industries India Ltd | 124.59 | 43.97 | 0.06% |
| Linde India Ltd | 134.84 | 17.68 | — |
| Deepak Nitrite Ltd | 37.76 | 5.46 | 0.39% |
IOLCP Stock Price Comparison
Compare IOLCP with any stock or ETFCompare IOLCP with any stock or ETF
IOLCP
IOLCP Holdings
IOLCP Shareholdings
IOLCP Promoter Holdings Trend
IOLCP Promoter Holdings Trend
IOLCP Institutional Holdings Trend
IOLCP Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
IOLCP Shareholding Pattern
IOLCP Shareholding Pattern
IOLCP Shareholding History
IOLCP Shareholding History
Foreign Institutions
Mutual Funds Invested in IOLCP
Mutual Funds Invested in IOLCP
Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 1 Mutual Funds holding IOL Chemicals and Pharmaceuticals Ltd
| Funds (Top 1) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0005% | Percentage of the fund’s portfolio invested in the stock 0.08% | Change in the portfolio weight of the stock over the last 3 months 0.02% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 83/109 (-2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing IOLCP stock
smallcases containing IOLCP stock
Looks like this stock is not in any smallcase yet.
IOLCP Events
IOLCP Events
IOLCP Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
IOLCP Dividend Trend
No dividend trend available
IOLCP Upcoming Dividends
IOLCP Upcoming Dividends
No upcoming dividends are available
IOLCP Past Dividends
IOLCP Past Dividends
Cash Dividend
Ex DateEx DateFeb 18, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 18, 2025
Cash Dividend
Ex DateEx DateFeb 16, 2024
Interim
Interim | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Feb 16, 2024
Cash Dividend
Ex DateEx DateFeb 17, 2023
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateFeb 15, 2022
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 15, 2022
Cash Dividend
Ex DateEx DateSep 8, 2021
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 8, 2021
IOLCP Stock News & Opinions
IOLCP Stock News & Opinions
Articles & Videos
Corporate
IOL Chemicals & Pharmaceuticals to conduct AGM
IOL Chemicals & Pharmaceuticals announced that the 38th Annual General Meeting(AGM) of the company will be held on 22 August 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 13.76% in the March 2025 quarter
Net profit of IOL Chemicals & Pharmaceuticals rose 13.76% to Rs 31.42 crore in the quarter ended March 2025 as against Rs 27.62 crore during the previous quarter ended March 2024. Sales rose 4.73% to Rs 527.78 crore in the quarter ended March 2025 as against Rs 503.92 crore during the previous quarter ended March 2024. For the full year,net profit declined 24.82% to Rs 101.07 crore in the year ended March 2025 as against Rs 134.43 crore during the previous year ended March 2024. Sales declined 2.51% to Rs 2079.21 crore in the year ended March 2025 as against Rs 2132.79 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales527.78503.92 5 2079.212132.79 -3 OPM %11.899.83 -9.7310.81 - PBDT63.2553.63 18 209.95244.56 -14 PBT44.7037.20 20 137.96181.65 -24 NP31.4227.62 14 101.07134.43 -25 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals to table results
IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
IOL Chemicals gets approval from CDE to export Ibuprofen to China
This approval authorizes the company to export Ibuprofen to the Chinese markets. Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID) effective in relieving pain, reducing inflammation, and lowering fever. IOL Chemicals & Pharmaceuticals is one of the leading pharmaceutical (APIs) Companies and a significant player in the specialty chemicals space with world-class facilities. IOLCP has a wide presence across major therapeutic categories like pain management, anti-convulsants, anti-diabetes, anti-cholesterol and anti-platelets. The company's consolidated net profit declined 11% to Rs 20.53 crore in Q3 FY25 as compared with Rs 23.08 crore in Q3 FY24. Net sales increased 0.6% YoY to Rs 523.30 crore in Q3 FY25. The scrip declined 1.01% to settle at Rs 65.42 on the BSE.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
IOL Chemicals jumps after receiving CEP for Quetiapine Fumarate
The said certification will enable the company to export Quetiapine Fumarate to European and other countries that accept CEPs. Quetiapine Fumarate is an antipsychotic drug which is widely used to treat various mental health disorders. IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer. The company's consolidated net profit declined 11% to Rs 20.53 crore in Q3 FY25 as compared with Rs 23.08 crore in Q3 FY24. Net sales increased marginally to Rs 523.30 crore in Q3 FY25, up .0.6% as compared with Rs 520.39 crore in Q3 FY24.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals fixes record date for interim dividend
IOL Chemicals & Pharmaceuticals has fixed 18 February 2025 as record date for interim dividend of Rs 4 per share for FY 2024-25. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Board of IOL Chemicals & Pharmaceuticals recommends interim dividend
IOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12 February 2025, inter alia, have recommended the interim dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit declines 11.05% in the December 2024 quarter
Net profit of IOL Chemicals & Pharmaceuticals declined 11.05% to Rs 20.53 crore in the quarter ended December 2024 as against Rs 23.08 crore during the previous quarter ended December 2023. Sales rose 0.56% to Rs 523.30 crore in the quarter ended December 2024 as against Rs 520.39 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales523.30520.39 1 OPM %8.968.52 - PBDT46.4848.43 -4 PBT27.8032.09 -13 NP20.5323.08 -11 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
IOL Chemicals & Pharmaceuticals to declare Quarterly Results
IOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
IOL Chemicals rises after board approves proposal to split shares in 1:5 ratio
Accordingly, the face value of each share of the company will change to Rs 2, which is one-fifth of its present face value of Rs 10. The company expects to complete the stock split proposal within a period of two months from the date of shareholder's approval. Offering rationale for the stock split proposal, IOL Chemicals said: 'The split of equity shares will make the shares more affordable, thereby increasing its attractiveness to a wider range of investors. This move is expected to potentially boost investor participation and improve liquidity in the market.' IOL Chemicals and Pharmaceuticals is a pharma API and speciality chemicals manufacturer. The company's consolidated net profit declined 49.4% to Rs 19.15 crore on 3.6% increase in net sales to Rs 525.75 crore in Q2 FY25 over Q2 FY24. Powered by Capital Market - Live
5 months agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 4.43%
Pledged promoter holdings is insignificant